Literature DB >> 25440273

Effect of timing and route of methylprednisolone administration during pediatric cardiac surgical procedures.

Juho Keski-Nisula1, Pertti K Suominen2, Klaus T Olkkola3, Kaija Peltola2, Pertti J Neuvonen4, Paula Tynkkynen2, Jukka T Salminen5, Sture Andersson6, Eero Pesonen7.   

Abstract

BACKGROUND: We compared the antiinflammatory and cardioprotective effects of the two most common regimens of corticosteroid administration in pediatric cardiac surgical procedures: a single dose delivered either at anesthesia induction or by cardiopulmonary bypass (CPB) prime.
METHODS: Forty-five children, aged between 1 and 18 months and undergoing ventricular septal or atrioventricular septal defect correction, were randomized in double-blind fashion into three groups. The anesthesia induction group received 30 mg/kg methylprednisolone intravenously after anesthesia induction, and the CPB-prime group received 30 mg/kg methylprednisolone by CPB circuit. The placebo group received saline solution. Plasma concentrations of methylprednisolone, interleukin (IL)-6, IL-8 and IL-10, and troponin were measured at anesthesia induction before the study drug, 30 minutes on CPB, after patients were weaned from CPB, and 6 hours after cessation of CPB.
RESULTS: Equally high methylprednisolone concentrations were detected in both methylprednisolone groups, but the measured peak concentration occurred earlier in the induction group. Significantly lower IL-8 concentrations were observed just after patients were weaned from and 6 hours after CPB in the anesthesia induction group compared with the placebo (p = 0.002, p = 0.001) and prime groups (p = 0.003, p = 0.006). Significant reductions of troponin were detected in both methylprednisolone groups compared with placebo (induction, p = 0.001; prime, p = 0.002) 6 hours after patients were weaned from CPB.
CONCLUSIONS: Methylprednisolone administration at anesthesia induction was superior in terms of antiinflammatory action. Methylprednisolone administration in CPB-prime only a few minutes before aortic cross-clamping and cardioplegia resulted in mean troponin reductions similar to those of administration at anesthesia induction. Corticosteroids may have direct cardioprotective properties, as reported in experimental studies.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25440273     DOI: 10.1016/j.athoracsur.2014.08.042

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Blood Versus Crystalloid Cardioplegia in Pediatric Cardiac Surgery: A Systematic Review and Meta-analysis.

Authors:  Konstantinos S Mylonas; Aspasia Tzani; Panagiotis Metaxas; Dimitrios Schizas; Vasileios Boikou; Konstantinos P Economopoulos
Journal:  Pediatr Cardiol       Date:  2017-09-25       Impact factor: 1.655

2.  Steroids in paediatric heart surgery: eminence or evidence-based practice?

Authors:  Daniel Fudulu; Stafford Lightman; Massimo Caputo; Gianni Angelini
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-04-03

3.  Meta-Analysis: Shouldn't Prophylactic Corticosteroids be Administered During Cardiac Surgery with Cardiopulmonary Bypass?

Authors:  Tianci Chai; Xinghui Zhuang; Mengyue Tian; Xiaojie Yang; Zhihuang Qiu; Shurong Xu; Meiling Cai; Yanjuan Lin; Liangwan Chen
Journal:  Front Surg       Date:  2022-06-01

Review 4.  Corticosteroids in Pediatric Heart Surgery: Myth or Reality.

Authors:  Daniel P Fudulu; Ben Gibbison; Thomas Upton; Serban C Stoica; Massimo Caputo; Stafford Lightman; Gianni D Angelini
Journal:  Front Pediatr       Date:  2018-04-20       Impact factor: 3.418

5.  Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass.

Authors:  Ben Gibbison; José Carlos Villalobos Lizardi; Karla Isis Avilés Martínez; Daniel P Fudulu; Miguel Angel Medina Andrade; Giordano Pérez-Gaxiola; Alvin Wl Schadenberg; Serban C Stoica; Stafford L Lightman; Gianni D Angelini; Barnaby C Reeves
Journal:  Cochrane Database Syst Rev       Date:  2020-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.